Pharmacyclics holds gains after takeout rumors

Pharmacyclics Inc. (NASDAQ:PCYC) held onto most of Wednesday's gains on rumors that the biotech is considering takeout bids from Johnson & Johnson (NYSE:JNJ)

Read the full 235 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE